Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Bestrophin 2 Blocking Peptide (AC1286)
Cat.#: ACPP-1286
Specifications
Despition Bestrophin 2 Blocking Peptide for Immmunodepletion, Competition Assay SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1409 Human TULP1 Protein (AC1409) 5 µg inquiry ACPP-1655 Human RAB23 Protein (AC1655) 5 µg inquiry ACPP-1027 Recombinant Human Ephrin A3 Protein (Fc Tag) (AC1027) 50 µg inquiry ACPP-1780 Human DYRK1A Protein (AC1780) 5 µg inquiry ACPP-1282 Human SIAH1 Protein (AC1282) 2 µg inquiry ACPP-1265 EDG8 Blocking Peptide (AC1265) 250 µg inquiry ACPP-1796 Human GAP43 Protein (AC1796) 2 µg inquiry ACPP-1241 Dopamine Receptor D4 Blocking Peptide (AC1241) 250 µg inquiry ACPP-1407 Human HOMER3 Protein (AC1407) 5 µg inquiry ACPP-1641 Adenylate cyclase 1 Blocking Peptide (AC1641) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket